Catalyst Pharmaceuticals, Inc. (CPRX)
22.70
-0.26
(-1.13%)
USD |
NASDAQ |
Jan 16, 16:00
22.70
0.00 (0.00%)
After-Hours: 20:00
Catalyst Pharmaceuticals Market Cap: 2.790B for Jan. 16, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Collegium Pharmaceutical, Inc. | 1.441B |
| ACADIA Pharmaceuticals, Inc. | 4.397B |
| Amicus Therapeutics, Inc. | 4.421B |
| Rigel Pharmaceuticals, Inc. | 680.31M |
| Krystal Biotech, Inc. | 8.265B |
Market Cap Related Metrics
| PE Ratio | 13.25 |
| PS Ratio | 4.985 |
| PEG Ratio | 0.2865 |
| Price to Book Value | 3.032 |
| Price to Free Cash Flow | 12.29 |
| Price | 22.70 |
| Earnings Yield | 7.55% |
| PEGY Ratio | 0.2865 |
| Operating PE Ratio | 11.14 |
| Normalized PE Ratio | 13.44 |